Absolute and Relative Contraindications for Abdominoplasty with Liposuction
Patients with BMI >40 kg/m², active smoking, uncontrolled diabetes, severe cardiovascular disease, recent DVT/PE, or inability to safely discontinue anticoagulation should be excluded from abdominoplasty with liposuction due to significantly elevated perioperative risks.
Absolute Contraindications
Severe Obesity (BMI >40 kg/m²)
- BMI >40 kg/m² is an absolute contraindication to elective abdominoplasty with liposuction 1
- Combined procedures in obese individuals significantly increase complication rates, with BMI being an independent predictor of major complications (RR 1.05 per unit increase) 1
- Perioperative complications are associated with extremely high BMI in bariatric surgery populations, with similar risks applicable to body contouring procedures 2
- Patients with BMI >40 should be counseled toward bariatric surgery first if they desire body contouring, as this addresses the underlying obesity and reduces surgical risk 3
Active Cardiovascular Disease
- Severe cardiovascular disease, decompensated heart failure, unstable coronary syndromes, or significant arrhythmias are absolute contraindications 2, 4
- Patients with diagnosed or occult coronary heart disease have substantially higher surgical risk, with cardiac complication rates of 6.8-15.3 per 1000 patients in obese surgical populations 2
- Any patient with functional capacity <4 METs (unable to climb one flight of stairs or walk 2 blocks) has increased perioperative cardiac risk requiring deferral until optimization 4
Recent Thromboembolic Events
- History of DVT or PE within the past 3 months is an absolute contraindication 2
- Confirmed VTE risk increases with combined procedures (0.06% for liposuction alone vs higher rates with combined procedures) 1
- Perioperative DVT/PE rates in surgical populations range from 0.4-1% even with prophylaxis 2
Uncontrolled Diabetes Mellitus
- Uncontrolled diabetes with HbA1c >8% or active diabetic complications is an absolute contraindication 2, 4
- Diabetes is a major clinical predictor requiring immediate evaluation and optimization before elective surgery 4
- COVID-19 data demonstrates that patients with diabetes and undergoing surgery have significantly worse outcomes, a principle applicable to elective procedures 2
Relative Contraindications Requiring Optimization
Active Smoking
- Active smoking within 4-6 weeks of surgery is a strong relative contraindication 1
- Smoking is an independent risk factor for complications and should prompt mandatory cessation before proceeding 4
- Wound infection, dehiscence, and fat necrosis rates are significantly elevated in smokers 5
Anticoagulation Therapy
- Patients on warfarin or NOACs who cannot safely discontinue therapy should not undergo elective abdominoplasty 6
- While DOACs may be as efficacious as warfarin in obese patients (BMI ≥35 kg/m²), the perioperative management requires careful planning 6
- Hematoma rates, though lower with lipoabdominoplasty (0.8% overall), increase significantly when anticoagulation cannot be held 5, 1
Chronic Obstructive Pulmonary Disease (COPD)
- Severe COPD or pulmonary disease requiring home oxygen is a relative contraindication 2
- COPD significantly increases mortality from perioperative complications 2
- Pulmonary complications occur in 0.1% of liposuction cases but increase substantially with underlying lung disease 1
Previous Extensive Abdominal Surgery
- Multiple prior abdominal surgeries with extensive scarring increase complication risk 2
- Previous surgery does not absolutely contraindicate abdominoplasty but requires careful patient selection and counseling about increased risks 5
- Wound complications (infection, dehiscence, fat necrosis) occur in 5.6% of cases and are higher with prior surgery 5
BMI Thresholds and Risk Stratification
Evidence-Based BMI Cutoffs
- BMI 35-40 kg/m² represents a gray zone requiring individualized assessment 3, 1
- Patients with BMI 35-39.9 kg/m² should only proceed if they have no other significant comorbidities 3
- BMI >40 kg/m² is a hard stop - these patients should pursue bariatric surgery first 3, 1
Combined Procedure Considerations
- Combined procedures significantly increase complication rates (RR 4.81) compared to abdominoplasty or liposuction alone 1
- The overall complication rate for abdominoplasty with liposuction is 10.5%, which is actually lower than abdominoplasty alone (13.0%) when performed by experienced surgeons 7
- However, this safety profile only applies to appropriately selected patients without the contraindications listed above 7
Critical Pitfalls to Avoid
Arbitrary Liposuction Volume Restrictions
- Regulations limiting liposuction to 500-1000 ml when combined with abdominoplasty are not evidence-based 7
- Increasing liposuction volume is not independently associated with increased complications when performed by board-certified plastic surgeons 7
- The focus should be on patient selection rather than arbitrary volume limits 7
Underestimating Cardiac Risk
- Physical examination and ECG often underestimate cardiac pathology in obese patients 2
- Body size alone may camouflage jugular venous distention, and heart sounds are often distant 2
- Baseline ECG should be obtained in all patients, as 20% have ischemic changes 4
Inadequate Preoperative Optimization
- Patients with poor functional capacity require cardiac evaluation with stress testing before proceeding 4
- Chronic kidney disease (creatinine ≥2 mg/dL) requires cardiac evaluation 4
- Depression, cognitive impairment, and frailty should not be overlooked as these increase perioperative risk 4
Facility and Surgeon Requirements
- Procedures should be performed by board-certified plastic surgeons with experience in combined procedures 7
- High-volume centers with experienced surgeons optimize outcomes 3
- Hospital settings paradoxically have higher complication rates (RR 1.36), likely reflecting patient selection bias toward higher-risk cases 1